{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:59:04Z","timestamp":1790945944862,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273160"],"award-info":[{"award-number":["82273160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["H2023072"],"award-info":[{"award-number":["H2023072"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","award":["XYFM202451"],"award-info":[{"award-number":["XYFM202451"]}],"id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmcl.2026.130555","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:22:57Z","timestamp":1769214177000},"page":"130555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel anticancer paeonol derivatives possessing a nitric oxide donor moiety as TrxR inhibitors: design, synthesis, biological evaluation"],"prefix":"10.1016","volume":"135","author":[{"given":"Ce","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panjunjie","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameng","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2026.130555_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41568-019-0231-8","article-title":"Outcompeting cancer","volume":"20","author":"Vishwakarma","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130555_bb0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130555_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bmcl.2026.130555_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2019.04.009","article-title":"Nitric oxide and interactions with reactive oxygen species in the development of melanoma, breast, and colon cancer: a redox signaling perspective","volume":"89","author":"Monteiro","year":"2019","journal-title":"Nitric Oxide"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130555_bb0025","article-title":"Reactive oxygen species of tumor microenvironment: harnessing for immunogenic cell death","volume":"1879","author":"Malla","year":"2024","journal-title":"BBA - Rev on Cancer"},{"key":"10.1016\/j.bmcl.2026.130555_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2015.07.002","article-title":"NO to cancer: the complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001","volume":"6","author":"Scicinski","year":"2015","journal-title":"Redox Biol"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130555_bb0035","first-page":"389","article-title":"A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation","volume":"83","author":"Huang","year":"2023","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130555_bb0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41419-023-05838-5","article-title":"Nitroglycerin: a comprehensive review in cancer therapy","volume":"14","author":"Meunier","year":"2023","journal-title":"Cell Death Dis"},{"issue":"18","key":"10.1016\/j.bmcl.2026.130555_bb0045","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1021\/acs.jmedchem.6b01672","article-title":"Nitric oxide donor-based Cancer therapy: advances and prospects","volume":"60","author":"Huang","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130555_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177478","article-title":"Piperlongumine induces ROS accumulation to reverse resistance of 5-FU in human colorectal cancer via targeting TrxR","volume":"997","author":"Zhou","year":"2025","journal-title":"Eur J Pharmacol"},{"issue":"45","key":"10.1016\/j.bmcl.2026.130555_bb0055","doi-asserted-by":"crossref","first-page":"20825","DOI":"10.1021\/jacs.2c08802","article-title":"Selenium atom-polarization effect determines TrxR-specific recognition of metallodrugs","volume":"144","author":"Chen","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2026.130555_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101341","article-title":"Thioredoxin reductase: an emerging pharmacologic target for radiosensitization of cancer","volume":"17","author":"Patwardhan","year":"2022","journal-title":"Transl Oncol"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130555_bb0065","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/cancers11081191","article-title":"Reactive oxygen species in the tumor microenvironment: an overview","volume":"11","author":"Weinberg","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130555_bb0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmcl.2026.130555_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112610","article-title":"Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy","volume":"204","author":"Qian","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130555_bb0080","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00280-019-03912-4","article-title":"The thioredoxin system and cancer therapy: a review","volume":"84","author":"Mohammadi","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130555_bb0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","article-title":"Covalent Modifiers: A Chemical Perspective on the Reactivity of \u03b1,\u03b2-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions","volume":"60","author":"Jackson","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130555_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1033003","article-title":"Michael acceptor molecules in natural products and their mechanism of action","volume":"13","author":"Liang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130555_bb0095","doi-asserted-by":"crossref","first-page":"11195","DOI":"10.1021\/acs.jmedchem.0c01128","article-title":"Design and SAR of Withangulatin a analogues that act as covalent TrxR inhibitors through the Michael addition reaction showing potential in Cancer treatment","volume":"63","author":"Wang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130555_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejmech.2018.07.013","article-title":"Novel curcumin analogue hybrids: synthesis and anticancer activity","volume":"156","author":"Wang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130555_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.lfs.2019.04.034","article-title":"Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells","volume":"227","author":"Xu","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.bmcl.2026.130555_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2016.11.011","article-title":"Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway","volume":"115","author":"Li","year":"2017","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130555_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbadis.2016.10.019","article-title":"Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase","volume":"1863","author":"Zhang","year":"2017","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130555_bb0120","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12951-024-02588-0","article-title":"pH\/GSH dual-responsive nanoparticle for auto-amplified tumor therapy of breast cancer","volume":"22","author":"Huang","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130555_bb0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12094-020-02455-y","article-title":"Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo","volume":"23","author":"Zhang","year":"2021","journal-title":"Clin Transl Oncol"},{"issue":"02","key":"10.1016\/j.bmcl.2026.130555_bb0130","first-page":"288","article-title":"Research progress on the anti-tumor effect and mechanism of paeonol","volume":"36","author":"Sun","year":"2025","journal-title":"Traditional Chinese Drug Research and Clinical Pharmacology"},{"key":"10.1016\/j.bmcl.2026.130555_bb0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.intimp.2019.04.033","article-title":"Paeonol: pharmacological effects and mechanisms of action","volume":"72","author":"Zhang","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130555_bb0140","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bmc.2011.10.074","article-title":"Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein","volume":"20","author":"Juvale","year":"2012","journal-title":"Bioorg Med Chem"},{"issue":"06","key":"10.1016\/j.bmcl.2026.130555_bb0145","first-page":"28","article-title":"Synthesis and anticancer activity of Paeonol chalcones derivatives","volume":"39","author":"Gu","year":"2023","journal-title":"J Shangqiu Normal Univ"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130555_bb0150","first-page":"1339","article-title":"Effects of ERK1\/2 S-nitrosylation on ERK1\/2 phosphorylation and cell survival in glioma cells","volume":"41","author":"Jin","year":"2018","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130555_bb0155","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/cancers11010064","article-title":"Paroxetine induces apoptosis of human breast Cancer MCF-7 cells through ca-and p38 MAP kinase-dependent ROS generation","volume":"11","author":"Cho","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bmcl.2026.130555_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115191","article-title":"Tumor killing by a dietary curcumin mono-carbonyl analog that works as a selective ROS generator via TrxR inhibition","volume":"250","author":"Liu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130555_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108329","article-title":"Berberrubine as a novel TrxR inhibitor enhances cisplatin sensitivity in the treatment of non-small cell lung cancer","volume":"158","author":"Chu","year":"2025","journal-title":"Bioorg Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:47:04Z","timestamp":1776602824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S0960894X26000223"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130555","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel anticancer paeonol derivatives possessing a nitric oxide donor moiety as TrxR inhibitors: design, synthesis, biological evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130555"}}